Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT04936074

Fusion or no Fusion After Decompression of the Spinal Cord in Patients With Degenerative Cervical Myelopathy

Led by Uppsala University Hospital · Updated on 2025-04-08

300

Participants Needed

1

Research Sites

571 weeks

Total Duration

On this page

Sponsors

U

Uppsala University Hospital

Lead Sponsor

K

Karolinska Institutet

Collaborating Sponsor

AI-Summary

What this Trial Is About

Background: Degenerative cervical myelopathy (DCM) is characterized by neck pain, neck stiffness, weakness, paresthesia, sphincter disturbance and balance disorder. The mean age for symptoms is 64 years and more men than women, 2.7:1, are affected. The most common level is C5-C6. DCM is the predominant cause of spinal cord dysfunction in the elderly worldwide. Surgical options include stand-alone laminectomy, laminectomy and fusion and laminoplasty. The preferable surgical approach is though, a matter of controversy. The objective of this study is to compare stand-alone laminectomy to laminectomy and fusion. Methods/Design: This is a multicenter randomized, controlled, parallel group non-inferiority trial. A total of 300 adult participants are allocated in a ratio of 1:1. The primary endpoint is reoperation for any reason within 5 years of follow-up. Sample size and power calculations were performed by estimating the reoperation rate after laminectomy to 3.4% and after laminectomy with fusion to 7.9% based on data from the Swedish spine registry (Swespine) on patients with DCM. Secondary outcomes are the patient derived modified Japanese orthopaedic association (P-mJOA) score, Neck disability index (NDI), European quality of life five dimensions (EQ-5D), Numeric rating scale (NRS) for neck and arm pain, Hospital anxiety and depression scale (HADS), development of kyphosis measured as the cervical sagittal vertical axis (cSVA) and, death. Clinical and radiological follow-up is performed at 3, 12, 24 and 60 months after surgery. The main inclusion criteria is 1-4 levels of DCM in the subaxial spine, C3-C7, with or without deformity. The REDcap will be used for safe data management. Data will be analyzed in the per protocol (PP) population, defined as randomized patients who are still alive without having emigrated or left the study after five years. Discussion: This will be the first randomized controlled trial comparing two of the most common surgical treatments for DCM; the posterior muscle-preserving selective laminectomy and posterior laminectomy with instrumented fusion. The results of the MyRanC study will provide surgical treatment recommendations for DCM. This may result in improvements in surgical treatment and clinical practice regarding DCM.

CONDITIONS

Official Title

Fusion or no Fusion After Decompression of the Spinal Cord in Patients With Degenerative Cervical Myelopathy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age greater than 18 years
  • 1-4 levels of degenerative cervical myelopathy in the lower neck spine, C3-C7, with or without mild deformity
  • Eligible for both laminectomy alone and laminectomy with fusion treatments
  • Able to understand and read Swedish
  • Symptoms of myelopathy with at least one clinical sign of the condition
  • No prior spine surgery
  • Psychosocially, mentally, and physically able to follow the study plan, attend visits, and complete forms
  • Signed informed consent before any study procedures
Not Eligible

You will not qualify if you...

  • Local kyphosis with a modified K-line minimum interval distance less than 4 mm
  • Spondylolisthesis greater than 4 mm and translation more than 2 mm on neck movement X-rays
  • Only soft disc herniations without bone spurs or ligament thickening
  • Active infection
  • Cancer
  • Trauma
  • Inflammatory diseases like rheumatoid arthritis, ankylosing spondylitis, or DISH
  • Systemic diseases including HIV
  • Significant lumbar or thoracic spinal disease likely needing surgery within 6 months
  • Ossification of the posterior longitudinal ligament (OPLL)
  • Parkinson's disease
  • Drug abuse, dementia, or other reasons suggesting poor follow-up adherence
  • Previous cervical spine surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Academic Hospital of Uppsala

Uppsala, Sweden, 75185

Actively Recruiting

Loading map...

Research Team

A

Anna MacDowall, MD, PhD

CONTACT

A

Adrian Elmi-Terander, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here